Dr. Tomás Pascual, will be co-presenting an educational talk alongside Sara Tolaney and Tatiana Prowell, MD - Aleix Prat #PrecisionOncology
ESMO - Eur. Oncology Hospital Clínic IDIBAPS Universitat de Barcelona SOLTI #cancerresearch

#Cancer #ESMO #ESMO 2024 #OncoDaily #Oncology

oncodaily.com/61692.html

Hola a todos! 👋 ¿Qué tema os gustaría tratar en el primer taller de SOLTIyoung? Si echáis algo en falta, ¡comentad abajo y lo intentaremos hacer realidad 💥!

NEW #CYCLIBTOOL revealed by Meritxell Bellet!

Can't wait for the May 15 relaunch with over 700 drugs to check interactions.

Make sure to visit @_solti at #ESMOBreast24 to see how CYCLIBTOOL can streamline your practice. 🚀

#beSOLTI

Empieza el primer OUTREACH del año! Estamos en el
Hospital Universitario Clínico San Cecilio con ganas de hablar sobre #cancerdemama triple negativo con la Dra. Isabel Blancas y el Dr. Tomás Pascual. Pásate!

#beSOLTI

Every day, I learn and am inspired by the dedication, knowledge and passion of these professionals and friends😀

Enhorabuena ‼️ a Confeticidad y A.C.La Sonrisa de la Vida por el éxito en su
“I Marcha Solidaria de la Alegría” que congregó ➕ 1.500 personas con voluntad #CancerMamaMetastasico deje de ser una amenaza vital

#HopeSolti
#EsperanzaActiva
#Sevilla

SOLTI #cancerresearch
Frente al Cancer #EsperanzaActiva
Consejería de Salud y Consumo

🔍 Reflecting on an insightful #BreastCancerResearch lab retreat!

🧬 Dived deep into our many ongoing projects, reaffirmed our shared vision and mission, and tackled the challenges ahead 🎯

💪 We are pushing the boundaries of what is possible in #CancerResearch 🎗️

💖 Incredibly…

👱‍♀️71yo,

Triple Negative Breast Cancer, HER2 2+ (ISH neg, ratio 1.4), Ki67 35%, TILs 10%, cT2 (25mm), cN0, cM0.

🎯Neoadjuvant tx: ddECx4 + wCBDCA/TAX + PEMBRO.

☢️MRI: >50% PR.

🔬Sur: ypT1c, ypN0, HR-, ‼️HER2 2+ ISH AMP RATIO 2.3‼️, ki67 2% TILs 20%, TLS+, RCB II.

⬇️Images

Retreatlab 2024

🔬 Excited to share our latest research published in npj Journals , where we explored the effects of cell-cycle inhibition and the immune microenvironment in breast cancer treated with ribociclib and letrozole vs. chemotherapy. A thread 🧵 nature.com/articles/s4152…

#BCSM

**US based MBC patients**

Diagnosed with HER2+ (positive) or HER2+/ER+ (triple positive) stage IV #metastaticbreastcancer ?

Have you considered stopping HER2 therapy?

Please share your experience by completing this anonymous survey @ redcap.link/TREAT_HER2

Please RT